COVID-19: Older drugs for a novel disease-Chloroquine, hydroxychloroquine, and possible Pentoxifylline-set to start the second innings?

COVID-19: Older drugs for a novel disease-Chloroquine, hydroxychloroquine, and possible Pentoxifylline-set to start the second innings?

Currently no drug is approved for the prophylaxis and management of COVID 19. Lots of activities on vaccine and trials with drugs are underway. Some evidence have shown positive results using older established drug in the management of severe cases. We are also of same view and opinion to adopt some...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of family medicine and primary care 2020-05, Vol.9 (5), p.2172-2175, Article 2172
Hauptverfasser: Thangaraju, Pugazhenthan, Gurunthalingam, Meenalotchini, Varthya, Shobanbabu, Venkatesan, Sajitha, Thangaraju, Eswaran
Format: Artikel
Sprache:eng
Schlagworte:
chloroquine
Coronaviruses
COVID-19
Drug approval
Drug therapy
Drugs
Hydroxychloroquine
Invited
Lopinavir
oseltamavir
Pentoxifylline
Vaccines
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Currently no drug is approved for the prophylaxis and management of COVID 19. Lots of activities on vaccine and trials with drugs are underway. Some evidence have shown positive results using older established drug in the management of severe cases. We are also of same view and opinion to adopt some emergency measure by pharmacological intervention till a newer drug available in the market.
ISSN:2249-4863
2278-7135
DOI:10.4103/jfmpc.jfmpc_422_20